3 employees
Trethera is a biotechnology company that discovers and develops small molecules that control DNA replication and integrity.
2013
$2M
from 2 investors over 2 rounds
Trethera raised $2M on May 30, 2023
Investors: National Cancer Institute
Trethera raised $1.6M on October 19, 2022
Investors: National Eye Institute (NEI)